Page last updated: 2024-11-08

biguanides and Anemia, Hypochromic

biguanides has been researched along with Anemia, Hypochromic in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Anemia, Hypochromic: Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gyr, K1
Berger, W1
Göschke, H1
Stalder, GA1

Trials

1 trial available for biguanides and Anemia, Hypochromic

ArticleYear
[Postprandial disorders following gastrectomy and their modifications by dimethylbiguanide].
    Deutsche medizinische Wochenschrift (1946), 1970, Nov-27, Volume: 95, Issue:48

    Topics: Adult; Anemia, Hypochromic; Antisocial Personality Disorder; Biguanides; Blood Glucose; Body Weight;

1970